BRIEF-AcelRx Pharmaceuticals initiates late-stage study of its painkiller
September 27, 2016 at 07:09 AM EDT
* Initiates phase 3 study of Zalviso in patients with moderate-to-severe acute post-operative pain Source text for Eikon: Further company coverage: